MetLife Declares Q4 2024 Preferred Stock Dividends

By Bobby Samwell • Saturday, November 16 10:18 • Permanent Link

MetLife, Inc. (NYSE: MET) has declared its fourth quarter 2024 preferred stock dividends. The company announced the following dividends:

Quarterly dividend of $0.39232690 per share on the company’s floating rate non-cumulative preferred stock, series A, with a liquidation preference of $25 per share (NYSE: MET PRA).
Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE).
Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).

These dividends will be payable on December 16, 2024, to shareholders of record as of Friday, November 29, 2024.

MetLife, Inc. (NYSE: MET) is a leading financial services company, providing insurance, annuities, employee benefits, and asset management. It has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe, and the Middle East. As a result of these announcements, the company's shares have moved 0.9% on the market, and are now trading at a price of $83.33. For the full picture, make sure to review MetLife's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.